| Serial Number | 79370455 |
| Word Mark | CAPDRIVE |
| Filing Date | Thursday, March 2, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, August 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, August 27, 2024 |
| Goods and Services | Stem cells for medical purposes; biochemical medicine for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; biological preparations for medical purposes, namely, for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; chemico-pharmaceutical preparations for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of ophthalmic, neurological, cardiovascular, and metabolic diseases; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the central nervous system; ophthalmological preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cardiovascular agents for medical purposes; cellular function activating agents for medical purposes; pharmaceutical products for the prevention and treatment of cancer |
| Pseudo Mark | CAP DRIVE |
| Goods and Services | Scientific research and development; scientific research; technological research, namely, research on the subject of pharmaceuticals; biological research; scientific research in the nature of conducting clinical trials for others; medical research; pharmaceutical research services; research on the subject of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; structural and functional analysis of genomes; biotechnology research; analysis of the mode of action of chemical combinations on animals; research and development services in the field of antibodies; genetic testing for scientific research purposes; biological research and analysis; pharmaceutical drug development services; DNA screening for scientific research purposes; medical research; testing of pharmaceuticals; biomedical research services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 26, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 26, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Skyline Therapeutics (Shanghai) Co.,Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Skyline Therapeutics (Shanghai) Co.,Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, May 25, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, May 26, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 30, 2023 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 1, 2023 | ASSIGNED TO EXAMINER |
| Friday, December 1, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, December 2, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 19, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, January 19, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, February 14, 2024 | REFUSAL PROCESSED BY IB |
| Friday, July 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 19, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 27, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 27, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, October 23, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 23, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |